HEALIOS KK chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.79
Dividend & YieldN/A¥ (N/A)
Beta 0.93
Market capitalization 17.59B
Operating cash flow -5.48B
ESG Scores unknown

Company description

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio2.72
Working Capital-0.47
Return On Equity-0.57
Debt To Equity0.79
Fixed Asset Ratio0.22
Fixed Interest Cover-9.23

Financial data

Financial Statements

Cashflow Statement 2014-12-31 2020-12-31 2021-12-31
Change To Liabilities -29M -36M
Total Cashflows From Investing Activities -1.22B -1.22B -736M
Net Borrowings 500M 500M
Total Cash From Financing Activities 803M 803M 6.99B
Change To Operating Activities 72M 72M 286M
Issuance Of Stock 440M 440M 6.76B
Net Income -480M -5.51B -4.91B
Change In Cash -4.37B -4.37B 1.2B
Effect Of Exchange Rate -13M -13M 40M
Total Cash From Operating Activities -3.94B -3.94B -5.09B
Depreciation 229M 229M 262M
Change To Account Receivables 46M 46M -130M
Other Cashflows From Financing Activities -137M -137M 229M
Change To Netincome 1.11B 1.11B -1.01B
Capital Expenditures -311M -311M -293M

Income Statement 2014-12-31 2020-12-31 2021-12-31
Research Development 2.99B 2.99B 3.7B
Income Before Tax -476M -5.38B -4.46B
Net Income -480M -5.51B -4.91B
Selling General Administrative 804M 1.16B 1.65B
Gross Profit 230M 27M 41M
Ebit -574M -4.2B -5.38B
Operating Income -574M -4.2B -5.38B
Interest Expense -1M -538M -583M
Income Tax Expense 6M 135M 450M
Total Revenue 279M 27M 41M
Cost Of Revenue 49M
Total Other Income ExpenseNet 98M -1.18B 918M
Net Income From Continuing Ops -482M -5.51B -4.91B
Net Income Applicable To Common Shares -480M -5.51B -4.91B

Balance Sheet Statement 2014-12-31 2020-12-31 2021-12-31
Total Liabilities 507M 15.32B 15.33B
Total Stockholder Equity 2.66B 7.84B 8.64B
Other Current Liabilities 475M 2.05B 734M
Total Assets 3.17B 23.17B 23.97B
Common Stock 1.53B 4.99B 6.18B
Other Current Assets 97M 566M 570M
Retained Earnings -434M -2.22B -2.69B
Treasury Stock 30M -172M -1.42B
Cash 1.95B 13.92B 15.13B
Total Current Liabilities 475M 2.69B 6.04B
Other Stockholder Equity 30M -172M -1.42B
Property, Plant, and Equipment 120M 996M 1.15B
Total Current Assets 2.06B 15.01B 16.43B
Net Tangible Assets 1.76B 3.9B 4.69B
Net Receivables 21M 264M 400M
Accounts Payable 435M 359M


Insider Transactions

Here are the insider transactions of stock shares related to HEALIOS KK:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to HEALIOS KK. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on HEALIOS KK

Here is the result of two systematic investment strategies applied to HEALIOS KK. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on HEALIOS KK

The following chart shows the equity curve of the two systematic investment strategies applied to HEALIOS KK:

HEALIOS KK automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -6.27% on the backtest period.

Performance at glance

Performance

-6.27 %

Latent gain

-660.0 ¥

Invested capital

10530.0 ¥

Annualized return

-1.49 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on HEALIOS KK

This is the result of two momentum investment strategies applied to HEALIOS KK. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on HEALIOS KK

The following chart shows all the entries opened by the momentum investment system on HEALIOS KK:

HEALIOS KK momentum entries
  • The first momentum investment strategy would give 8.68% of return on HEALIOS KK. That represents 788.0¥ of latent gain with 9082.0¥ of employed capital.
  • The second momentum investment strategy would give 7.55% of return on HEALIOS KK. That represents 693.0¥ of latent gain with 9177.0¥ of employed capital.
Performance at glance (1Q Momentum)

Performance

8.68 %

Latent gain

788.0 ¥

Invested capital

9082.0 ¥

Annualized return

2.57 %
Performance at glance (2Q Momentum)

Performance

7.55 %

Latent gain

693.0 ¥

Invested capital

9177.0 ¥

Annualized return

2.03 %

Momentum equity curve on HEALIOS KK

The following chart shows the equity curve of the two momentum strategies applied to HEALIOS KK:

HEALIOS KK momentum equity

Note: the dividends potentially given by HEALIOS KK are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on HEALIOS KK

The following chart shows the employed capital evolution of the two momentum strategies on HEALIOS KK since the beginning:

HEALIOS KK

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.


Buy the dip strategy result on HEALIOS KK

Buy the dip entry openings on HEALIOS KK

HEALIOS KK

The performance achieved by the robo-advisor on HEALIOS KK is 5.65%. That represents 528.0$ of latent gain with 9342.0¥ of employed capital. The following chart shows HEALIOS KK stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of HEALIOS KK, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

5.65 %

Latent gain

528.0 ¥

Invested capital

9342.0 ¥

Annualized return

2.57 %

Equity curve of the strategy applied to HEALIOS KK

The following chart shows the result of the investment strategy applied to HEALIOS KK:

HEALIOS KK

Note: the dividends potentially given by HEALIOS KK are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on HEALIOS KK

The following chart shows the employed capital evolution since the beginning of the investment strategy on HEALIOS KK:

HEALIOS KK

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on HEALIOS KK

In this section, I will compare the three previous investment strategies applied to HEALIOS KK.

Equity curve comparison on HEALIOS KK

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

HEALIOS KK investment strategy comparison

Employed capital comparison on HEALIOS KK

HEALIOS KK investment comparison

Performance comparison on HEALIOS KK

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -6.27% -660.0¥ 10530.0¥ -1.49%
Momentum 1 quarter 8.68% 788.0¥ 9082.0¥ 2.19%
Momentum 2 quarters 7.55% 693.0¥ 9177.0¥ 2.03%
Non-directional 5.65% 528.0¥ 9342.0¥ 2.57%
Annualized return comparison

Automatic investment

-1.49 %

Momentum 1Q

2.03 %

Momentum 2Q

2.03 %

Non-directional

2.57 %

Correlated stocks

Here are the most positively and negatively correlated stocks with HEALIOS KK:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between HEALIOS KK and the other stocks. There may be false positives or some missing correlated stocks. If the price of HEALIOS KK does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name HEALIOS KK
Country Japan
City Tokyo
Address Yurakucho Denki Building
Phone
Website www.healios.co.jp
FullTime employees 116
Industry Biotechnology
Sector Healthcare
Exchange XTKS
Ticker 4593.XTKS
Market www.jpx.co.jp

HEALIOS KK ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown